Patent · US Active

Pharmaceutical formulation

US7727958B2 · kind B2 · utility

8Cited by
14References
9Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 4, 2007
Grant dateJun 1, 2010
Priority date
Expiry dateSep 4, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical formulation for a PKC modulatory peptide and a transport moiety comprising the aforementioned components and an anti-aggregant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.